       Document 0065
 DOCN  M9640065
 TI    From the Food and Drug Administration.
 DT    9604
 AU    Nightingale SL; Office of Health Affairs, FDA, Rockville, MD 20857, USA.
 SO    JAMA. 1996 Jan 24-31;275(4):273. Unique Identifier : AIDSLINE
       MED/96144522
 DE    Carcinoma, Renal Cell/DRUG THERAPY  *Drug Approval  *Drugs,
       Investigational  Glioma/DRUG THERAPY  Human  HIV Protease
       Inhibitors/*THERAPEUTIC USE  Information Services
       Isoquinolines/*THERAPEUTIC USE  Kidney Neoplasms/DRUG THERAPY
       Publishing/*STANDARDS  Quinolines/*THERAPEUTIC USE  United States
       United States Food and Drug Administration  JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).

